Similar articles

• Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.

  Mead GM, Green JA, Macbeth FR, Williams CJ, Whitehouse JM, Buchanan R. Mead GM, et al. Cancer Treat Rep. 1983 Apr;67(4):410. Cancer Treat Rep. 1983. PMID: 6189603 No abstract available.
• Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.

  Rees GJ, Slade RR, Hopes P. Rees GJ, et al. Eur J Cancer Clin Oncol. 1982 Nov;18(11):1125-9. doi: 10.1016/0277-5379(82)90093-1. Eur J Cancer Clin Oncol. 1982. PMID: 6186497
• Combined management of malignant teratoma of the testis.

  Peckham MJ, McElwain TJ, Barrett A, Hendry WF. Peckham MJ, et al. Lancet. 1979 Aug 11;2(8137):267-70. doi: 10.1016/s0140-6736(79)90288-5. Lancet. 1979. PMID: 88606
• Cancer of the testis: a new paradigm.

  Einhorn LH. Einhorn LH. Hosp Pract (Off Ed). 1986 Apr 15;21(4):165-72, 175-8. Hosp Pract (Off Ed). 1986. PMID: 2420812 Review. No abstract available.
• [Chemotherapy of testicular tumors].

  Cortes Funes H, Leiva Galvis O. Cortes Funes H, et al. Actas Urol Esp. 1981 Sep-Oct;5(5):259-72. Actas Urol Esp. 1981. PMID: 6174033 Review. Spanish. No abstract available.